Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II

Journal of Clinical Investigation

Volumn 110, Issue 1, 2002, Pages 61-69

  Qi, Zhonghua ^a   Hao, Chuan Ming ^a   Langenbach, Robert I ^b   Breyer, Richard M ^a   Redha, Reyadh ^a   Morrow, Jason D ^a   Breyer, Matthew D ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DIURESIS; EDEMA; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HYPERTENSION; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY MEDULLA; KNOCKOUT GENE; MALE; MICTURITION; MOUSE; NATRIURESIS; NEPHROTOXICITY; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; VASODILATATION;

EID: 0036308753     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214752     Document Type: Article

References (65)

1. The coxibs, selective inhibitors of cyclooxygenase-2
2. Cyclooxygenase 2 and the kidney
3. Cyclooxygenase-2-specific inhibitors and cardiorenal function: A randomized, controlled trial of celecoxib and role coxib in older hypertensive osteoarthritis patients
4. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An underrecognized public health problem
5. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence
6. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
7. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
8. Corcoran Memorial Lecture. The role of eicosanoids in angiotensin-dependent hypertension
9. Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor
10. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
11. Prostaglandin endoperoxide H synthases-1 and -2
12. Regulation of renal function by prostaglandin E receptors
13. Why there are two cyclooxygenase isozymes
14. Pharmacological analysis of cyclooxygenase-1 in inflammation
15. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
16. Characterization of murine vasopressor and vasodepressor prostaglandin E2 receptors
17. Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics
18. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
19. Biphasic actions of prostaglandin E(2) on the renal afferent arteriole: Role of EP(3) and EP(4) receptors
20. Human prostacyclin synthase gene and hypertension: The Suita Study
21. Plasma thromboxane B2 concentration in pulmonary hypertension associated with congenital heart disease
22. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein
23. Regulated formation of eicosanoids
24. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2
25. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function
26. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
27. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase
28. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: Implications for the use of cyclooxygenase inhibitors
29. The renal medulla and hypertension
30. The renal medullary microcirculation
31. Influence of prostaglandins on papillary blood flow and pressure-natriuretic response
32. Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells
33. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development
34. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
35. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
36. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells
37. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
38. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells
39. Blood pressure control: Special role of the kidneys and body fluids
40. Evidence of an important and direct role for protein kinase C in agonist induced phosphorylation leading to desensitization of the angiotensin AT1A receptor
41. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
42. Physiological regulation of cyclooxygenase-2 in the kidney
43. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet
44. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2
45. Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition
46. Cyclooxygenase 2 and neuronal nitric oxide synthase expression in the renal cortex are not interdependent in states of salt deficiency
47. Role of renocottical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion
48. Arachidonic acid elicits endothelium-dependent release from the rabbit aorta of a constrictor prostanoid resembling prostaglandin endoperoxides
49. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension
50. Reciprocal effects of dexamethasone on vasodilatory responses to arachidonic
51. Assessment of changes in intrarenal blood flow in conscious rats using laser-Doppler flowmetry
52. Intrarenal blood flow: Microvascular anatomy and the regulation of medullary perfusion
53. Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin
54. Effects of celecoxib and naproxen on renal function in the elderly
55. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
56. Role of nitric oxide in renal papillary blood flow and sodium excretion
57. Inhibition of sodium transport by prostaglandin E2 across the isolated perfused rabbit collecting tubule
58. Prosraglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium
59. Prostaglandin E receptors and the kidney
60. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. Selective inhibitions of the medullary portion
61. Effects of adenosine on intrarenal oxygenation
62. Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival
63. Analgesic nephropathy
64. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesul- fonamide (SC-58635, celecoxib)
65. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain